Tengjun Biotechnology Corp.
TJBH
Revenue
8.52M
▼-49.63M▼-85.35%
3 Months ChangeAssets
438.96M
▲265.04M▲152.39%
3 Months ChangeLiabilities
423.70M
▲265.54M▲167.90%
3 Months ChangeFree Cash Flow
7.48M
▲6.22M▲494.53%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-11-17
Form 8-K
ID: 0001213900-23-088327
2023-10-10
Form 8-K
ID: 0001013762-23-002833
2023-09-29
Form 8-K
ID: 0001213900-23-081039
2023-08-15
Form 10-Q
ID: 0001213900-23-067340
2023-08-14
Form 8-K
ID: 0001213900-23-067084
2023-08-07
Form 8-K
ID: 0001213900-23-064063
2023-05-15
Form 10-Q
ID: 0001213900-23-039845
2023-05-08
Form 8-K
ID: 0001213900-23-037377
2023-03-24
Form 8-K
ID: 0001213900-23-022830
2023-01-10
Form 8-K
ID: 0001213900-23-002030